|
72
|
272
|
9yufA |
Pkr kinase domain - dabrafenib complex |
|
31
|
134
|
9ozbA |
Crystal structure of fosa from pseudomonas aeruginosa and bromomethyl phosphonic acid |
|
109
|
339
|
10hmA |
Trypanosoma brucei clk1 kinase domain in complex with a covalent amidobenzimidazole (ab4) inhibitor |
|
33
|
134
|
9ozaA |
Crystal structure of fosa from pseudomonas aeruginosa with manganese and chloromethylphosphonic acid |
|
290
|
1016
|
9l3rA |
Human pi3kdelta in complex with zandelisib |
|
79
|
170
|
9l3rB |
Human pi3kdelta in complex with zandelisib |
|
92
|
321
|
9msrA |
Bdtx-1535 in complex with wt egfr |
|
108
|
309
|
9nzlA |
Crystal structure of yck2 with djs-02-24-06 |
|
107
|
306
|
9nzkA |
Crystal structure of yck2 with ly364947 |
|
82
|
271
|
9d5iA |
Crystal structure of the ilk mutant (r225a)/alpha-parvin core complex bound to mgatp |
|
85
|
271
|
9d5hA |
Crystal structure of the ilk mutant (r371q)/alpha-parvin core complex bound to gefitinib |
|
83
|
271
|
9d5fA |
Crystal structure of the ilk/alpha-parvin core complex bound to bosutinib |
|
39
|
124
|
9d5iB |
Crystal structure of the ilk mutant (r225a)/alpha-parvin core complex bound to mgatp |
|
84
|
271
|
9d5gAAAA |
Crystal structure of the ilk/alpha-parvin core complex bound to 4-methyl erlotinib |
|
83
|
271
|
9d5eA |
Crystal structure of the ilk/alpha-parvin core complex bound to gefitinib |
|
86
|
283
|
9d0rA |
Crystal structure of human wee1 kinase domain in complex with inhibitor |
|
41
|
124
|
9d5eB |
Crystal structure of the ilk/alpha-parvin core complex bound to gefitinib |
|
87
|
271
|
9d5pA |
Crystal structure of the ilk/alpha-parvin core complex bound to erlotinib |
|
40
|
124
|
9d5gBBBB |
Crystal structure of the ilk/alpha-parvin core complex bound to 4-methyl erlotinib |
|
41
|
124
|
9d5fB |
Crystal structure of the ilk/alpha-parvin core complex bound to bosutinib |
|
88
|
368
|
9z2fA |
Mitochondrial creatine kinase in complex with adp and uncompetitive inhibitor uci |
|
38
|
124
|
9d5pB |
Crystal structure of the ilk/alpha-parvin core complex bound to erlotinib |
|
38
|
124
|
9d5hB |
Crystal structure of the ilk mutant (r371q)/alpha-parvin core complex bound to gefitinib |
|
90
|
368
|
9z2dA |
Mitochondrial creatine kinase in complex with adp, creatine, and uncompetitive inhibitor uci |
|
82
|
288
|
9q32A |
Rip1 kinase domain in complex with compound 1 |
|
83
|
288
|
9q31A |
Rip1 kinase domain in complex with gdc-8264 |
|
57
|
269
|
9lusA |
Structure of human g9a set-domain in complex with flav27 inhibitor |
|
81
|
268
|
10iaA |
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 12 ((10as,13as)-3-cyclopropyl-1-methyl-8-(trifluoromethyl)-3,4,10a,11,13a,14-hexahydro-10h,13h-9,5-(azeno)furo[3,4-k]pyrazolo[4,3-b][1,4,6,10]oxatriazacyclotridecine) |
|
82
|
268
|
10hzA |
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 7 ((10as,13as)-3-cyclobutyl-1-methyl-8-(trifluoromethyl)-3,4,10a,11,13a,14-hexahydro-10h,13h-9,5-(azeno)furo[3,4-k]pyrazolo[4,3-b][1,4,6,10]oxatriazacyclotridecine) |
|
83
|
267
|
10hyA |
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 1 ((11r)-8-chloro-3,11-dimethyl-2-(oxan-4-yl)-2,4,10,11,12,13-hexahydro-9,5-(azeno)pyrazolo[3,4-b][1,4,6,10]oxatriazacyclotridecine) |
|
91
|
283
|
9ymtA |
Staphylococcus aureus serine/threonine kinase stk1 with inhibitor gw779439x |
|
80
|
272
|
9oo9A |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 6 |
|
81
|
272
|
9oofA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 10e |
|
82
|
272
|
9ooaA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 7 |
|
81
|
272
|
9oocA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 10a |
|
84
|
272
|
9oobA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 8 |
|
75
|
272
|
9oodA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 10c |
|
84
|
272
|
9oojA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 18c |
|
79
|
272
|
9ooeA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 10d |
|
81
|
272
|
9oohA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 10b |
|
98
|
347
|
9pe9A |
Gsk3beta in complex with compound 6 |
|
81
|
292
|
9pe7A |
Cdk6 to cdk4 active site surrogate in complex with compound 6 |
|
81
|
292
|
9pe8A |
Cdk6 to cdk4 active site surrogate in complex with pf-07220060 |
|
127
|
427
|
9ef8A |
Crystal structure of cryptosporidium parvum n-myristoyltransferase with bound myristoyl-coa and inhibitor 20084 |
|
135
|
426
|
9ef7A |
Crystal structure of cryptosporidium parvum n-myristoyltransferase with bound myristoyl-coa and inhibitor 20057 |
|
106
|
350
|
9ytyA |
Human p38 alpha mapk:mw01-7-081asrm inhibitor complex |
|
134
|
426
|
9ef6A |
Crystal structure of cryptosporidium parvum n-myristoyltransferase with bound myristoyl-coa and inhibitor 20045 |
|
434
|
1450
|
9n36A |
Cryoem structure of respiratory syncytial virus polymerase with novel non-nucleoside inhibitor compound 22 |
|
79
|
288
|
9mzzA |
Crystal structure of ripk1 with compound 36 |
|
20
|
98
|
9n36B |
Cryoem structure of respiratory syncytial virus polymerase with novel non-nucleoside inhibitor compound 22 |
